Published in J Immunotoxicol on January 01, 2004
Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study. Arthritis Care Res (Hoboken) (2011) 1.64
The effects of maternal exposure to bisphenol A on allergic lung inflammation into adulthood. Toxicol Sci (2012) 1.00
Approaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric population. Toxicol Sci (2009) 0.85
Therapeutic approaches using host defence peptides to tackle herpes virus infections. Viruses (2009) 0.78
Rheumatoid Arthritis in Agricultural Health Study Spouses: Associations with Pesticides and Other Farm Exposures. Environ Health Perspect (2016) 0.75
Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment. Curr Protoc Toxicol (2016) 0.75
Immunotoxicology: A brief history, current status and strategies for future immunotoxicity assessment. Curr Opin Toxicol (2017) 0.75
Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid. Epidemiology (2013) 2.13
Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J (2002) 1.79
Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. FASEB J (2006) 1.61
Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ Health Perspect (2006) 1.57
Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol (2009) 1.55
Physiological role of tumor necrosis factor alpha in traumatic muscle injury. FASEB J (2002) 1.42
Arsenic and atherosclerosis. Toxicol Appl Pharmacol (2004) 1.33
Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice. Environ Health Perspect (2003) 1.22
Role of CC chemokines in skeletal muscle functional restoration after injury. Am J Physiol Cell Physiol (2004) 1.14
c-Src-dependent activation of the epidermal growth factor receptor and mitogen-activated protein kinase pathway by arsenic. Role in carcinogenesis. J Biol Chem (2001) 1.08
Genotyping of single nucleotide polymorphisms in cytokine genes using real-time PCR allelic discrimination technology. Cytokine (2004) 1.07
Inhalation of toluene diisocyanate vapor induces allergic rhinitis in mice. J Immunol (2007) 1.06
Exposure and immunological determinants in a murine model for toluene diisocyanate (TDI) asthma. Toxicol Sci (2004) 1.04
Meeting report: moving upstream-evaluating adverse upstream end points for improved risk assessment and decision-making. Environ Health Perspect (2008) 0.98
Cytokine polymorphisms in silicosis and other pneumoconioses. Mol Cell Biochem (2002) 0.98
Inflammatory mediators and skeletal muscle injury: a DNA microarray analysis. J Interferon Cytokine Res (2003) 0.97
Influence of cytokine gene variations on immunization to childhood vaccines. Vaccine (2009) 0.97
Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol (2005) 0.95
The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J Toxicol Environ Health B Crit Rev (2006) 0.95
Immune mediators in a murine model for occupational asthma: studies with toluene diisocyanate. Toxicol Sci (2004) 0.93
CTNNA3 (α-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population. Toxicol Sci (2012) 0.93
Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate. Toxicol Sci (2013) 0.90
Cytokine polymorphisms play a role in susceptibility to ultraviolet B-induced modulation of immune responses after hepatitis B vaccination. J Immunol (2003) 0.90
Role of tumor necrosis factor in toluene diisocyanate asthma. Am J Respir Cell Mol Biol (2002) 0.89
IL-1beta gene polymorphisms influence hepatitis B vaccination. Vaccine (2002) 0.89
Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL/6 mice. Vaccine (2005) 0.89
Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Environ Health Perspect (2013) 0.88
Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations. Vaccine (2013) 0.86
Genetic susceptibility in pneumoconiosis. Toxicol Lett (2006) 0.85
Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population. Am J Epidemiol (2011) 0.84
Symposium summary: children's health risk--what's so special about the developing immune system? Toxicol Appl Pharmacol (2004) 0.83
Clinical outcomes for the elderly patient receiving a tracheotomy. Head Neck (2004) 0.83
Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma. Toxicol Sci (2012) 0.82
Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study. Neurobiol Aging (2005) 0.82
Winter season, frequent hand washing, and irritant patch test reactions to detergents are associated with hand dermatitis in health care workers. Dermatitis (2013) 0.82
Hexamethylene diisocyanate asthma is associated with genetic polymorphisms of CD14, IL-13, and IL-4 receptor α. J Allergy Clin Immunol (2011) 0.82
Arsenic carcinogenicity: relevance of c-Src activation. Mol Cell Biochem (2002) 0.81
A proposed testing framework for developmental immunotoxicology (DIT). Toxicol Sci (2004) 0.80
Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced Asthma. J Occup Environ Med (2014) 0.79
Insights into the quantitative relationship between sensitization and challenge for allergic contact dermatitis reactions. Toxicol Appl Pharmacol (2002) 0.79
Animal models for diisocyanate asthma: answers for lingering questions. Curr Opin Allergy Clin Immunol (2004) 0.79
A statistical model for assessing genetic susceptibility as a risk factor in multifactorial diseases: lessons from occupational asthma. Environ Health Perspect (2006) 0.78
Benzene and Its Principal Metabolites Modulate Proinflammatory Cytokines and Growth Factors in Human Epidermal Keratinocyte Cultures. In Vitro Toxicol (1997) 0.77
Immunotoxicology testing: past and future. Methods Mol Biol (2010) 0.77
Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process. Toxicol Sci (2006) 0.77
Association of cytokine gene polymorphisms with rate of decline in lung function. J Occup Environ Med (2008) 0.77
Variation in the WBC differential count and other factors associated with reporting of herpes labialis: a population-based study of adults. FEMS Immunol Med Microbiol (2007) 0.76
Quinacrine-induced occlusive fibrosis in the human fallopian tube is due to a unique inflammatory response and modification of repair mechanisms. J Reprod Immunol (2013) 0.76
Cytokine polymorphisms in chronic inflammatory diseases with reference to occupational diseases. Curr Mol Med (2003) 0.76
An alternative interpretation of, "A lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats". Regul Toxicol Pharmacol (2010) 0.75
N-Acetyltransferase 2 Genotypes Are Associated With Diisocyanate-Induced Asthma. J Occup Environ Med (2015) 0.75
Genetic Basis of Irritant Susceptibility in Health Care Workers. J Occup Environ Med (2016) 0.75
Immunotoxicology: fifty years of global scientific progress. J Immunotoxicol (2012) 0.75
Predicting outcome in aged and severely ill patients with prolonged respiratory failure. Ann Otol Rhinol Laryngol (2005) 0.75